Yahoo Finance September 15, 2020
Joshua Franklin

(Reuters) – After adapting to working from home in the COVID-19 pandemic, cash-rich technology and healthcare companies have now mastered dealmaking from home.

This week, Nvidia Corp unveiled a $40 billion agreement to acquire chip maker Arm Ltd from SoftBank Group Corp, while Gilead Sciences Inc inked a $21 billion deal for biotech company Immunomedics Inc.

They are the latest examples of companies whose business is minimally affected by, or in some cases benefiting from, the pandemic’s financial fallout and which are embarking on big acquisitions.

“They’ve largely learned to do work from home for their own business, and now it’s about strategic deployment of capital,” said Tom Miles, co-head of mergers and acquisitions (M&A) for the Americas at Morgan...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, Technology, Trends
In the Pipeline: LifeSpire of Virginia Announces $80M Renovation Plan; Oak Trace Completes Multiphase $112M Campus Redevelopment
Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024
Digital health venture capital deals stagnate
Ascension continues selling spree
Acadia Executes 3 New Acquisitions, Fueling 2024 Growth Strategy

Share This Article